Abstract

Get full access to this article
View all access options for this article.
References
1.
Bergogne-Berezin
E.
2001 . The increasing role of Acinetobacter species as nosocomial pathogens . Curr. Infect. Dis. Rep . 3 :440 –444 .
2.
Perez
F.
,
Hujer
A.M
,
Hujer
K.M
,
Decker
B.K
,
Rather
P.N
, and
Bonomo
R.A.
. 2007 . Global challenge of multidrug-resistant Acinetobacter baumannii . Antimicrob. Agents Chemother . 51 :3471 –3484 .
3.
Stein
A.
, and
Raoult
D.
. 2002 . Colistin: an antimicrobial for the 21st century? Clin . Infect. Dis . 35 :901 –902 .
4.
5.
Lescat
M.
,
Poirel
L.
,
Jayol
A.
, and
Nordmann
P.
. 2019 . Performances of the rapid polymyxin acinetobacter and pseudomonas tests for colistin susceptibility testing . Microb. Drug Resist . 25 :520 –523 .
